GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Knight Therapeutics Inc (FRA:04K) » Definitions » Cyclically Adjusted Book per Share

Knight Therapeutics (FRA:04K) Cyclically Adjusted Book per Share : €5.37 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Knight Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Knight Therapeutics's adjusted book value per share for the three months ended in Mar. 2024 was €5.118. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €5.37 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-06-10), Knight Therapeutics's current stock price is €3.88. Knight Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €5.37. Knight Therapeutics's Cyclically Adjusted PB Ratio of today is 0.72.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Knight Therapeutics was 0.79. The lowest was 0.70. And the median was 0.74.


Knight Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Knight Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Knight Therapeutics Cyclically Adjusted Book per Share Chart

Knight Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 5.12

Knight Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 5.12 5.37

Competitive Comparison of Knight Therapeutics's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Knight Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Knight Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Knight Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Knight Therapeutics's Cyclically Adjusted PB Ratio falls into.



Knight Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Knight Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.118/126.2576*126.2576
=5.118

Current CPI (Mar. 2024) = 126.2576.

Knight Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201406 2.260 99.473 2.869
201409 2.360 99.394 2.998
201412 3.709 98.367 4.761
201503 4.094 99.789 5.180
201506 4.074 100.500 5.118
201509 4.061 100.421 5.106
201512 4.154 99.947 5.248
201603 4.151 101.054 5.186
201606 4.491 102.002 5.559
201609 4.454 101.765 5.526
201612 4.879 101.449 6.072
201703 4.811 102.634 5.918
201706 4.596 103.029 5.632
201709 4.692 103.345 5.732
201712 4.593 103.345 5.611
201803 4.397 105.004 5.287
201806 4.627 105.557 5.534
201809 4.697 105.636 5.614
201812 4.717 105.399 5.651
201903 4.784 106.979 5.646
201906 4.886 107.690 5.728
201909 4.845 107.611 5.685
201912 4.085 107.769 4.786
202003 3.806 107.927 4.452
202006 3.963 108.401 4.616
202009 4.343 108.164 5.069
202012 4.374 108.559 5.087
202103 4.382 110.298 5.016
202106 4.807 111.720 5.433
202109 4.789 112.905 5.355
202112 4.943 113.774 5.485
202203 5.105 117.646 5.479
202206 5.348 120.806 5.589
202209 5.678 120.648 5.942
202212 5.114 120.964 5.338
202303 5.078 122.702 5.225
202306 5.232 124.203 5.319
202309 5.406 125.230 5.450
202312 5.046 125.072 5.094
202403 5.118 126.258 5.118

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Knight Therapeutics  (FRA:04K) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Knight Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.88/5.37
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Knight Therapeutics was 0.79. The lowest was 0.70. And the median was 0.74.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Knight Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Knight Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Knight Therapeutics (FRA:04K) Business Description

Traded in Other Exchanges
Address
3400 De Maisonneuve West, Suite 1055, Montreal, QC, CAN, H3Z 3B8
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Ltin America and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.

Knight Therapeutics (FRA:04K) Headlines

No Headlines